Recruitment is set to begin in the coming weeks for a Phase IV patient study to evaluate the ability of Canopus’ Neutraceutical product, Total Calm and Focus™ to alleviate stress and anxiety in patients.
This study is being carried out at the Swinburne University in Australia on behalf of Canopus.
United States Office
Canopus BioPharma Inc
12400 Ventura Blvd
Suite 426,
Studio City
CA 91604
info@canopusbiopharma.com
European Headquarters
Canopus BioPharma Inc
Baybush, Straffan
Co. Kildare, Ireland
Telephone: +353 1 627 2636
Fax: +353 1 627 9028
info@canopusbiopharma.com
Australian Office
Canopus BioPharma Inc
Kenilworth Stn, PO Box 716,
Oxley Street, Bourke,
NSW 2830, Australia
Tel: +61 2 6874 7830
Fax: +61 2 6874 7884
South African Office
Canopus BioPharma Inc
P.O.Box. 92051
Flaming Rock Cresent
Mooikloof 0059
Pretoria
